Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cedric Hermans

Showing results (141-150 of 222) with videos related to

Pageof 23
Sort By:
Advances in Therapy|April 26, 2020
Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International AnalysisCedric Hermans, Renato Marino, Catherine Lambert, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 16, 2004
Determinants of serum levels of surfactant proteins A and B and Clara cell protein CC16Cedric Hermans, Ping Dong, Marjorie Robin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 15, 2018
Does haemophilia slow down the development of liver fibrosis?Marie-Astrid van Dievoet, Isabelle Leclercq, Cedric Hermans, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 14, 2020
Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo projectDagmar M Hajducek, Pierre Chelle, Cedric Hermans, et al.
Gait & Posture|November 21, 2016
3D Multi-segment foot kinematics in children: A developmental study in typically developing boysKevin Deschamps, Filip Staes, Kathelijne Peerlinck, et al.
Plos One|August 18, 2012
Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activityXavier Stephenne, Emanuele Nicastro, Stephane Eeckhoudt, et al.
Therapeutic Advances in Hematology|February 19, 2024
The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international studyMargareth C Ozelo, Cedric Hermans, Manuel Carcao, et al.
Journal of Thrombosis and Haemostasis : JTH|April 12, 2026
Diagnosis and management of hemophilia A and BMing Y Lim, Jesús Ardila, Giancarlo Castaman, et al.
Blood Transfusion = Trasfusione Del Sangue|January 13, 2018
Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical managementGary Benson, Günter Auerswald, Gerry Dolan, et al.
Journal of Clinical Medicine|February 25, 2022
IDELVION: A Comprehensive Review of Clinical Trial and Real-World DataMiguel Escobar, Maria Elisa Mancuso, Cedric Hermans, et al.
Pageof 23

Showing results (141-150 of 222) with videos related to

Sort By:
Pageof 23
Advances in Therapy|April 26, 2020
Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International AnalysisCedric Hermans, Renato Marino, Catherine Lambert, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 16, 2004
Determinants of serum levels of surfactant proteins A and B and Clara cell protein CC16Cedric Hermans, Ping Dong, Marjorie Robin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 15, 2018
Does haemophilia slow down the development of liver fibrosis?Marie-Astrid van Dievoet, Isabelle Leclercq, Cedric Hermans, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 14, 2020
Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo projectDagmar M Hajducek, Pierre Chelle, Cedric Hermans, et al.
Gait & Posture|November 21, 2016
3D Multi-segment foot kinematics in children: A developmental study in typically developing boysKevin Deschamps, Filip Staes, Kathelijne Peerlinck, et al.
Plos One|August 18, 2012
Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activityXavier Stephenne, Emanuele Nicastro, Stephane Eeckhoudt, et al.
Therapeutic Advances in Hematology|February 19, 2024
The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international studyMargareth C Ozelo, Cedric Hermans, Manuel Carcao, et al.
Journal of Thrombosis and Haemostasis : JTH|April 12, 2026
Diagnosis and management of hemophilia A and BMing Y Lim, Jesús Ardila, Giancarlo Castaman, et al.
Blood Transfusion = Trasfusione Del Sangue|January 13, 2018
Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical managementGary Benson, Günter Auerswald, Gerry Dolan, et al.
Journal of Clinical Medicine|February 25, 2022
IDELVION: A Comprehensive Review of Clinical Trial and Real-World DataMiguel Escobar, Maria Elisa Mancuso, Cedric Hermans, et al.
Pageof 23